Publications by authors named "Marc Marien"

Claim this Profile
N
Noradrenergic influences in the basolateral amygdala on inhibitory avoidance memory are mediated by an action on α2-adrenoceptors.
Barbara Ferry, Sandrine Parrot, Marc Marien, Christine Lazarus, Jean-Christophe Cassel

Psychoneuroendocrinology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylxanthines and ryanodine receptor channels.
Serge Guerreiro, Marc Marien, Patrick P Michel

Handb Exp Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequences.
Bernard Vacher, Philippe Funes, Philippe Chopin, Didier Cussac, Peter Heusler, Marc Marien

J Med Chem· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
Olivier Blin, Christine Audebert, Séverine Pitel, Arthur Kaladjian, Catherine Casse-Perrot, Marc Marien

Psychopharmacology (Berl)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter release.
Marie-Bernadette Assié, Ouissame Mnie-Filali, Véronique Ravailhe, Christelle Benas, Marc Marien

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novelty determines the effects of olfactory enrichment on memory and neurogenesis through noradrenergic mechanisms.
Alexandra Veyrac, Joëlle Sacquet, Véronique Nguyen, Marc Marien, François Jourdan

Neuropsychopharmacology· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
Daniel Alvarez-Fischer, Serge Guerreiro, Stéphane Hunot, Françoise Saurini, Marc Marien

J Neurochem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.
Serge Guerreiro, Damien Toulorge, Etienne Hirsch, Marc Marien, Pierre Sokoloff

Mol Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouse.
Alexandra Veyrac, Véronique Nguyen, Marc Marien, Anne Didier, François Jourdan

Learn Mem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist.
Sergey Kalinin, Paul E Polak, Jose L M Madrigal, Vitaliy Gavrilyuk, Anthony Sharp, Marc Marien

Antioxid Redox Signal· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular hippocampal acetylcholine level controls amygdala function and promotes adaptive conditioned emotional response.
Ludovic Calandreau, Pierre Trifilieff, Nicole Mons, Laurence Costes, Marc Marien

J Neurosci· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Sabine Traver, Marc Marien, Elodie Martin, Etienne C Hirsch, Patrick P Michel

Mol Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.
Pamela Rizk, Julio Salazar, Rita Raisman-Vozari, Marc Marien, Merle Ruberg

Neuropsychopharmacology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of noradrenergic transmission by alpha2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb.
Alexandra Veyrac, Anne Didier, Francis Colpaert, François Jourdan, Marc Marien

Exp Neurol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress.
Sabine Traver, Bénédicte Salthun-Lassalle, Marc Marien, Etienne C Hirsch, Francis Colpaert

Mol Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.
Thomas Debeir, Laure Ginestet, Chantal François, Stéphanie Laurens, Jean-Claude Martel, Marc Marien

Exp Neurol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys.
Edward F Domino, Lisong Ni, Francis Colpaert, Marc Marien

Recept Channels· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noradrenergic mechanisms in neurodegenerative diseases: a theory.
Marc R Marien, Francis C Colpaert, Alan C Rosenquist

Brain Res Brain Res Rev· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia.
Howard T J Mount, Jean-Claude Martel, Paul Fluit, Yingji Wu, Eleanor Gallo-Hendrikx, Marc R Marien

J Neurochem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PARP inhibitor benzamide protects against kainate and NMDA but not AMPA lesioning of the mouse striatum in vivo.
Cristina Cosi, Karen Guerin, Marc Marien, Wouter Koek, Karin Rollet

Brain Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
Anne-Sophie Villégier, Candice Drouin, Jean-Charles Bizot, Marc Marien, Jacques Glowinski

Synapse· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons.
Jean-Denis Troadec, Marc Marien, Sophie Mourlevat, Thomas Debeir, Merle Ruberg

Mol Pharmacol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
Philippe Chopin, Francis C Colpaert, Marc Marien

J Pharmacol Exp Ther· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis